Salix Pharmaceuticals

Salix Pharmaceuticals, Inc. Earnings Call scheduled for Mon, Aug 4 (CCBN)

yahoo.com     Jul 21, 2008          

Salix Pharmaceuticals, Inc. Earnings Conference Call (Q2 2008) Scheduled to start Mon, Aug 4, 2008, 5:00 pm Eastern After the event has finished, the audio will be available from this page until Wed, Aug 5, 2009 Salix...                

comments

Salix Pharmaceuticals Announces 2Q2008 Financial Results Conference Call and Webcast (Business Wire)

yahoo.com     Jul 21, 2008          

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP - News ) today announced that the Company will report second quarter ended June 30, 2008 financial results following the close of the U.S. financial...                

comments

                   

Zacks Sell List Highlights: Coventry Health Care, AU Optronics Corp, Saks, Salix Pharmaceuticals...

yahoo.com     Jul 18, 2008   25 related          

CHICAGO----Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 : Coventry Health Care, Inc....                

comments

Salix Initiates Phase 3 For Rifaximin In Non-Constipation Irritable Bowel Syndrome

medicalnewsblog.info     Jul 4, 2008          

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the Company has initiated patient enrollment in TARGET 1 and TARGET 2, its Phase 3, randomized, double-blind, placebo-controlled, multicenter studies to assess the...                

comments

Salix Initiates Phase III Irritable Bowel Syndrome Trial

redorbit.com     Jul 1, 2008   9 related          

Salix Pharmaceuticals has initiated patient enrollment in Target 1 and Target 2, its Phase III, randomized, double-blind, placebo-controlled, multicenter studies to assess the efficacy and safety of rifaximin 550mg, dosed three...                

comments

Salix Pharmaceuticals Ltd (NASD:SLXP) Weekly Earnings Information

pharmiweb.co.uk     Jun 22, 2008   11 related          

Released : Sunday, June 22, 2008 2:09 AM Company: Salix Pharmaceuticals Ltd (NASD:SLXP) Actual EPS for FY End (12/2007): 0.88 Current FY High EPS Estimate: -1.12 Current FY Low EPS Estimate: -1.30 Current FY Consensus Estimate:...                

comments

                   

SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Change in Directors or Principal Officers,...

yahoo.com     Jun 19, 2008          

| Request a Trial to NEW EDGAR Online Pro Form 8-K for SALIX PHARMACEUTICALS LTD Change in Directors or Principal Officers, Financial Statements and Exh Item 5.02. Departure of Directors or Certain Officers; Election of...                

comments

                   

National Pharmaceutical Company to Sponsor Popular Kansas City Walk

prnewswire.com     Jun 12, 2008   2 related          

Salix teams up with Crohn's & Colitis Foundation of America for this year's Take Steps event KANSAS CITY, Mo., June 12 /PRNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) is happy to announce that Salix...                

comments

                   

Challenges for Sell-Rated Salix (Zacks.com)

yahoo.com     Jun 3, 2008          

Tuesday June 3, 1:02 pm ET By Jason Napodano, CFA We maintain a Sell rating on Salix Pharmaceuticals, Ltd. (NasdaqGS: SLXP - News), which suffered a major setback in last December when the FDA granted approval to three generic...                

comments

                   

Salix Presents New Rifaximin Phase IIb Data Demonstrating Significant And Sustained Improvement...

drugs.com     May 30, 2008          

Results Presented at Digestive Disease Week 2008 Further Support Potential of Non-absorbed, Gut-selective Antibiotic as Novel Treatment for IBS Symptoms SAN DIEGO, CA - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced findings from two analyses of the Phase IIb clinical trial of...                

comments

1 2 3 4 5 next »